资讯
3 天
格隆汇 on MSN拜耳的前列腺癌药物获FDA批准格隆汇6月4日|拜耳(Bayer)表示,其药物Nubeqa已获得美国食品药品管理局(Food and Drug ...
The FDA said in a safety warning issued in mid-May that some patients who have taken oral allergy medicines daily for long periods of time, at least a few months but often several years, have ...
近日,科兴制药与东曜药业合作的出海产品——贝伐珠单抗生物类似药,获得尼日利亚食品药品监督管理局(NATIONAL AGENCY FOR FOOD AND DRUG ADMINISTRATION AND CONTROL)上市批准。 本次获批的贝伐珠单抗注射液,用于治疗转移性结直肠癌,晚期、转移性或复发性非小细胞肺癌,复发性胶质母细胞瘤,上皮性卵巢癌、输卵管癌或原发性腹膜癌,宫颈癌。该产品在尼日利亚获 ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果